Clinical trials: Hyperphosphatemia Patients on Hemodialysis
- Condition Hyperphosphatemia Patients on Hemodialysis
- Funder type Industry (pharma, biotech, devices)
- Age group Children (under 18)
Chronic Renal Failure Patients With Hyperphosphataemia Receiving Hemodialysis
Post-marketing Surveillance of Kiklin Capsules in Hemodialysis Patients
The purpose of this survey is to evaluate the safety and efficacy of long-term use of Kiklin® Capsules in actual clinical settings.
- Trial name
- NCT01901107
- Testing
- Kiklin capsules
- Where
- 8 sites in Japan
- Volunteers
- 1,078 people
- Sponsor
- Astellas Pharma Inc